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Abstract
Background Combination of laparoscopic approach with ERAS protocol in colorectal surgery allows for an early discharge. 
However there is a risk that some of the discharged patients are developing, asymptomatic at the time, infectious complica-
tions. This may lead to a delay in diagnostics and proper treatment introduction. We aimed to assess the usefulness of pre-
operative plasma albumin concentration and their changes as indicators of infectious complications in patients undergoing 
colorectal cancer surgery.
Methods Prospective analysis included 105 consecutive patients who underwent laparoscopic colorectal cancer resection 
between August 2014 and September 2016. In all cases standardised 16-item perioperative care ERAS protocol was used 
(mean compliance > 85%). Patients with IBD, distant metastases, undergoing emergency or multivisceral resection were 
excluded. Blood samples were collected preoperatively and on POD 1, 2, 3. Plasma albumin concentration was measured. 
Patients were divided into two groups depending on the presence of infectious complications. We analysed the differences 
in the levels of albumin and the dynamics of changes.
Results Group 1—82 not complicated patients, Group 2—23 patients with at least one infectious complication. Preopera-
tively, there were no significant differences in the levels of serum albumin between those groups (Group 1—38.7 ± 4.9 g/l; 
Group 2—37.7 ± 5.0 g/l). In postoperative period, decrease was observed in both (POD 1: Group 1—36.5 ± 4.2 g/l, 
Group 2—34.7 ± 4.2 g/l, p = 0.07; POD 2: Group 1—36.2 ± 4.1 g/l, Group 2—32.6 ± 5.6 g/l, p = 0.01; POD 3: Group 
1—36.0 ± 4.4 g/l, Group 2—30.9 ± 3.5 g/l, p = 0.01). The decrease was significantly greater in Group 2 on POD 2 and 3.
Conclusions We showed that a regular measurement of albumin in the early postoperative days may be beneficial in the 
detection of postoperative infectious complications. Although changes in albumins are observed early after surgery, this 
parameter is relatively unspecific.
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Colorectal cancer surgery is associated with a relatively 
high morbidity rate, which depends on multiple factors and 
can occur in 30–40% of patients [1, 2]. One of the signifi-
cant components affecting those parameters is the surgical 
technique. It has been shown that the laparoscopic approach 
is correlated with reduced morbidity [3, 4]. Moreover, the 
implementation of multimodal perioperative care protocols 
enhanced recovery after surgery (ERAS) further decreases 
postoperative complications by approximately 20–40% and 
leads to early hospital discharge after 2–5 days [5–8]. These 
factors markedly shortened length of stay (LOS). Some 
complications (i.e. anastomotic leakage) can occur late 
after surgery, even on postoperative day (POD) 8–12. This 
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means that in most cases they are diagnosed after discharge 
[9]. For these reasons, markers that allow early detection of 
complications and prediction of their severity, ideally before 
patients become symptomatic, are the area of interest for 
many surgeons.
Albumin, which is mostly used as a nutritional marker 
and a predictor for outcomes, is a protein which imme-
diately responds to surgical stress. An albumin drop is 
observed in most major abdominal surgeries within the 
first postoperative hours [10–12]. Although pathophysi-
ological basics of albumin kinetics are well-established, 
this parameter is rarely used as a marker of complica-
tions in the early postoperative period. Also, the albumin 
level correlates with the surgical trauma and postopera-
tive stress response [13]. It is important in the context of 
laparoscopy and ERAS protocol, since they both signifi-
cantly reduce the degree of surgical stress [14, 15]. That 
is why it seems reasonable to establish whether regular 
assessments of albumin level in the early postoperative 
phase are clinically relevant.
Aim
The aim of this study was to evaluate the usefulness of 
albumin level measurements as an early predictor of 
infectious complications in patients with colorectal can-
cer undergoing laparoscopic surgery with ERAS protocol.
Materials and methods
The study was conducted in a tertiary referral centre (uni-
versity hospital). Consecutive patients undergoing laparo-
scopic resection for colorectal cancer were prospectively 
analysed. Inclusion criteria were age over 18 years old, 
elective laparoscopic surgery for verified colorectal adeno-
carcinoma and ERAS protocol in perioperative care. We 
excluded patients who underwent open or emergency sur-
gery and those in which resection exceeding the large bowel 
(T4) was required. Patients with inflammatory bowel disease 
were excluded from the study as well as cases where it was 
not possible to implement ERAS protocol (i.e. due to hospi-
talisation in ICU). Other exclusion criteria included distant 
metastases (M1), rectal cancer treated with transanal endo-
scopic microsurgery, conversion to open resection, patients 
with an active infection or autoimmune systemic disease. 
Moreover, we excluded patients in whom infectious compli-
cations were diagnosed within the first 48 h postoperatively.
A laparoscopic approach with five or six trocars and 
medial to lateral technique was used [16]. All patients had 
the exact same perioperative care ERAS protocol (Table 1), 
which has been used in our department for 5 years. Mean 
compliance with the protocol is over 80% [17].
Blood samples for albumin measurements were drawn 
from the patients four times: on the day of surgery and on 
the three following PODs. Albumin measurements were 
included in the routine biochemistry panel; they were per-
formed in serum on the day of blood collection using the 
automated analyser Cobas 6000 (Roche Diagnostics, Basel, 
Switzerland).
Table 1  ERAS protocol used in our unit
1 Preoperative counselling and patient’s education
2 No bowel preparation (oral lavage in the case of low rectal resection with TME and defunctioning loop ileostomy)
3 Preoperative carbohydrate loading (400 ml of Nutricia preOp® 2 h prior surgery)
4 Antithrombotic prophylaxis (Clexane® 40 mg sc. starting in the evening prior surgery)
5 Antibiotic prophylaxis (preoperative cefuroxime 1.5 g + metronidazole 0.5 g iv. 30–60 min prior surgery)
6 Laparoscopic surgery
7 Balanced intravenous fluid therapy (< 2500 ml intravenous fluids during the day of surgery, less than 150 mmol sodium)
8 No nasogastric tubes postoperatively
9 No drains left routinely for colonic resections, one drain placed for < 24 h in case of TME
10 Transversus abdominis plane (TAP) block, epidural anaesthesia in cases with high risk of conversion
11 Avoiding opioids, multimodal analgesia (oral when possible—paracetamol 4 × 1 g, ibuprofen 2 × 200 mg, metamizole 2 × 2.5 g, or ketoprofen 
2 × 100 mg)
12 Prevention of postoperative nausea and vomiting (PONV) (dexamethasone 8 mg iv., ondansetron 8 mg iv., metoclopramide 10 mg iv.)
13 Postoperative oxygenation therapy (4–6 l/min)
14 Early oral feeding (oral nutritional supplement 4 h postoperatively, light hospital diet and oral nutritional supplements on the first postopera-
tive day, full hospital diet on the second postoperative day)
15 Urinary catheter removal on the first postoperative day
16 Full mobilisation on the first postoperative day (getting out of bed, going to toilet, walking along the corridor, at least 4 h out of bed)
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Serum samples were obtained by centrifuging blood, col-
lected without anticoagulant, for 10 min at 4000 rpm on a 
MPW 351e centrifuge (MPW Med. Instruments, Warsaw, 
Poland; Rotor No. 12,436). The reference interval for albu-
min was 35–50 g/l.
Patients were divided into Groups 1 and 2 that included 
patients without and with infectious complications, respec-
tively. The diagnosis of these complications and assessment 
of their severity was performed according to ECDC guide-
lines [18].
Groups were compared for age, sex, body mass index 
(BMI), American Society of Anaesthesiologists (ASA) 
score, type of surgery, tumour staging, operative time and 
intraoperative blood loss. Differences in albumin level 
between groups were analysed on consecutive PODs. 
Due to the high variability in preoperative measurements, 
Δ-increments were calculated each day (i.e. ΔPOD1: differ-
ence of concentration on POD1 and POD0; ΔPOD2: differ-
ence of concentration on POD2 and POD0 etc). Addition-
ally, albumin level ratios were calculated (i.e. POD1/0, POD 
3/0, POD 3/1 etc.).
Statistical analysis
All data were analysed with Statsoft STATISTICA v.12. 
The results are presented as mean ± standard deviation (SD), 
median and interquartile range (IQR). The study of categori-
cal variables used the Chi-square test of independence. The 
Shapiro–Wilk test was used to check for a normal distribu-
tion of data and the Student t test was used for normally 
distributed quantitative data. For non-normally distributed 
quantitative variables, the Mann–Whitney U test was used. 
For dependent variables the Friedman test was used. A 
receiver operating characteristic (ROC) curve was applied 
to obtain the area under the curve (AUC) and determine the 
best cut-offs. Results were considered statistically significant 
when p value was less than 0.05.
The study was approved by the local Ethics Review Com-
mittee (Approval Number KBET/211/B/2014). All proce-
dures were performed in accordance with the ethical stand-
ards laid down in the 1964 Declaration of Helsinki and its 
later amendments.
Results
192 patients in our department underwent colorectal resec-
tion between August 2014 and September 2016. 41 of them 
did not fulfil inclusion criteria and were initially excluded. 
44 were excluded during surgery. Two patients were 
excluded because ERAS protocol was not implemented in 
the postoperative period. Patients’ flow through the study 
and reasons for exclusion are shown in Fig. 1.
Groups 1 and 2 consisted of 82 (78.1%) and 23 (21.9%) 
patients, respectively. Table 2 shows a demographic analysis 
of groups. No significant differences were noticed regarding 
their demography, ASA scale, type of performed surgery, 
operative time, intraoperative blood loss and cancer stage. 
However, there were significant differences between the 
groups in median LOS (4 vs. 9 days, p < 0.001) and read-
mission rate (4.9 vs. 17.4%, p = 0.046). In addition, we did 
not notice differences in mean intravenous fluids transfused 
during the surgical procedure and first 24 h postoperatively 
(2134 ± 665 vs. 2333 ± 901 ml, p = 0.42). The compliance 
with restrictive intravenous fluid therapy according to ERAS 
protocol was 91.4 vs. 87.1% in Group 1 and 2, respectively 
(p = 0.51).
The overall infectious complication rate was 21.9%. An 
analysis of infectious complications is presented in Table 3.
Laboratory measurements are presented in Table  4. 
Before surgery (POD 0 measurement), albumin levels were 
comparable between groups (p = 0.58). On POD 1, the 
albumin levels decreased in both groups, but the difference 
between Groups was not statistically significant (p = 0.07). 
On POD 2 and 3, the albumin levels in Group 1 were lower 
than in Group 2 (p = 0.001, p = 0.00001) (Fig. 2). Fried-
man’s ANOVA showed differences in consecutive albumin 
measurements in both groups (p = 0.00012 in Group 1 and 
p < 0.00001 in Group 2). When Δ-albumin increments were 
analysed, the differences were significant only in Group 2 
(p = 0.38 in Group 1 and p = 0.00006 in Group 2). Similarly, 
differences in albumin ratios were statistically significant 
only in Group 2 (p = 0.38 in Group 1 and p = 0.00006 in 
Group 2) (Figs.3, 4).
A ROC curve was used to determine the optimal cut-
off of albumin levels, Δ-albumin increments and albumin 
ratios in consecutive days. This analysis showed that meas-
urements on POD3 were characterised by highest specificity 
and sensitivity. Figures 5, 6, 7 and 8 show ROC curves and 
their characteristics.
Discussion
This study showed that regardless of the occurrence of 
complications, there was a reduction in the albumin level 
in the early PODs after laparoscopic colorectal resection 
with perioperative ERAS protocol. In addition, it was more 
pronounced in patients with complications. Moreover, we 
observed that among uncomplicated cases the level of albu-
mins after initial rapid drop in the first POD remained stable 
over the next days. In patients who developed complications, 
albumins decreased further in the consecutive days. That 
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also reflected on the analysis of albumin level derivatives 
such as Δ-albumin increments and ratios.
Most studies focus on the preoperative level of hypoalbu-
minemia and its influence on outcomes. Relatively few pub-
lications analysed it as a potential marker of early adverse 
events, and therefore it is seldom used as a biomarker of 
complications [12, 13, 19, 20]. However, albumin, which 
is considered a negative acute phase protein with a half-
life of 20 days, seems to have perfect characteristics for a 
useful biomarker [19]. It is easy to measure, widely avail-
able and inexpensive. In addition, its kinetics allows for 
measurements within first postoperative hours [13, 21]. 
Fig. 1  Patients flow through the study
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Unfortunately, albumin is rather unspecific, and therefore it 
cannot exactly predict the underlying cause of its changes.
We focused on albumin, since it is an easy to assess bio-
chemical marker, familiar to most clinicians, and routinely 
measured in every laboratory. However, apart from albumin, 
there are other negative acute phase proteins such as trans-
ferrin, transthyretin, retinol-binding protein, antithrombin, 
transcortin, cortisol-binding globulin, transthyretin [22]. 
Although their decrease is observed in inflammation and 
they were extensively studied some time ago, according to 
our knowledge they were never investigated as useful mark-
ers of inflammatory complications after surgical procedures. 
This still needs to be investigated whether other negative 
acute phase proteins may in the future be used for early 
detection of complications.
According to previous studies, early postoperative albu-
min drop is associated with altered metabolism, blood loss, 
dilution or redistribution into the third space [10, 12, 13, 23]. 
Albumin production is inhibited in an acute condition, which 
enables increased production of acute phase proteins such as 
CRP or fibrinogen. It has been shown in experimental stud-
ies that 77% of the postoperative albumin decrease was due 
to redistribution, while 18 and 6% were attributed to blood 
loss and catabolism, respectively [10]. Interestingly, redis-
tribution is strongly correlated with systemic inflammatory 
response observed in major abdominal surgeries and practi-
cally non-existent in minor procedures [10, 23].
In contrast to previously published data, rapid postop-
erative albumin drop in our study was relatively low, 2 g/l 
(5.1%) in Group 1 and 5 g/l (12.5%) in Group 2. This is 
Table 2  Demographic analysis 
of patient groups
Parameter Group 1
(uncomplicated)
Group 2
(complicated)
p value
Number of patients [n (%)] 82 (78.1%) 23 (21.9%) –
Females [n (%)] 39 (47.6%) 12 (52.2%) 0.69572
Males [n (%)] 43 (52.4%) 11 (47.8%)
Mean age (years ± SD) 63.2 ± 13.4 65.3 ± 13.5 0.62947
BMI (kg/m2 ± SD) 26.7 ± 5.0 26.8 ± 5.0 0.75312
ASA 1 [n (%)] 1 (1.2%) 1 (4.3%) 0.6609
ASA 2 [n (%)] 53 (64.6%) 14 (60.9%)
ASA 3 [n (%)] 27 (33%) 7 (30.4%)
ASA 4 [n (%)] 1 (1.2%) 1 (4.3%)
Any comorbidity [n (%)] 64 (78%) 17 (73.9%) 0.67663
Cardiovascular [n (%)] 30 (36.6%) 8 (34.8%) 0.87442
Hypertension [n (%)] 42 (51.2%) 12 (52.2%) 0.93331
Diabetes [n (%)] 15 (18.3%) 5 (21.7%) 0.71028
Pulmonary disease [n (%)] 6 (7.3%) 3 (13%) 0.38584
Renal disease [n (%)] 6 (7.3%) 2 (8.7%) 0.82658
Liver disease [n (%)] 4 (4.9%) 1 (4.3%) 0.91647
AJCC Stage I [n (%)] 37 (45.1%) 10 (43.5%) 0.63179
AJCC Stage II [n (%)] 24 (29.3%) 5 (21.7%)
AJCC Stage III [n (%)] 21 (25.6%) 8 (34.8%)
Colonic resection [n (%)] 53 (64.6%) 16 (69.6%) 0.65748
Rectal resection [n (%)] 29 (35.4%) 7 (30.4%)
Mean operative time (min ± SD) 194.4 ± 56.7 215.3 ± 73.3 0.44429
Median operative time [min (IQR)] 190 (160–230) 180 (170–275)
Mean intraoperative blood loss (ml ± SD) 113.0 ± 118.4 128.4 ± 107.6 0.55006
Median intraoperative blood loss [ml (IQR)] 100 (50–150) 100 (50–200)
Mean length of hospital stay (days, range) 4.8 ± 4.0 10.8 ± 6.7 0.00003
Median length of hospital stay (days, IQR) 4 (3–6) 9 (6–18)
Readmission [n (%)] 4 (4.9%) 4 (17.4%) 0.04561
Table 3  Types of complications
Anastomotic leakage 9 (8.6%)
Surgical site infection—deep or superficial 6 (5.7%)
Intraperitoneal abscess 2 (1.9%)
Urinary tract infection 3 (2.8%)
Pneumonia 2 (1.9%)
Infectious diarrhoea (C. difficile) 1 (1.0%)
3230 Surgical Endoscopy (2018) 32:3225–3233
1 3
different from previously published data, where a 20–35% 
drop was observed [12, 13]. In these studies, however, the 
greatest decrease in albumin level was observed in patients 
undergoing liver surgery [19]. There are two potential 
Table 4  Analysis of biochemical parameters
Parameter Group 1
(uncomplicated)
Group 2
(complicated)
p value
Mean albumin ± SD (median, IQR) (g/l) POD 0 38.7 ± 4.9 (39, 36–42) 37.7 ± 5.0 (40, 35–41) 0.58702
POD 1 36.5 ± 4.2 (37, 34–39) 34.7 ± 4.2 (35, 30–37) 0.07131
POD 2 36.2 ± 4.1 (37, 34–39) 32.6 ± 5.6 (33, 30–36) 0.00996
POD 3 36.0 ± 4.4 (36, 34–39) 30.9 ± 3.5 (31, 28–32) 0.00004
Δ-albumin ± SD (median) (g/l) POD 1 − 2.6 ± 4.1 (− 2, − 5 to 1) − 3.0 ± 4.6 (− 4, − 6 to 0) 0.68309
POD 2 − 2.9 ± 4.5 (− 3, − 6 to 0) − 5.2 ± 5.3 (− 6, − 8 to − 1) 0.04953
POD 3 − 3.2 ± 4.4 (− 3, − 6 to 0) − 7.2 ± 4.7 (− 7, − 10 to − 5) 0.00306
Albumin POD 1/POD 0, mean ± SD (median, IQR) 0.94 ± 0.09 (0.94, 0.88–1.02) 0.93 ± 0.13 (0.9, 0.85–1) 0.27379
Albumin POD 2/POD 0, mean ± SD (median, IQR) 0.93 ± 0.11 (0.93, 0.84–1.0) 0.83 ± 0.24 (0.86, 0.79–0.94) 0.02905
Albumin POD 3/POD 0, mean ± SD (median, IQR) 0.92 ± 0.11 (0.91, 0.83–1.0) 0.82 ± 0.11 (0.82, 0.76–0.89) 0.00481
Albumin POD 2/POD 1, mean ± SD (median, IQR) 0.99 ± 0.1 (1, 0.94–1.05) 0.92 ± 0.1 (0.9, 0.86–1.03) 0.01294
Albumin POD 3/POD 1, mean ± SD (median, IQR) 1.0 ± 0.12 (0.97, 0.86–1.03) 0.87 ± 0.08 (0.86, 0.83–0.91) 0.00002
Fig. 2  Mean albumin levels in Group 1 and Group 2 in consecutive 
days
Fig. 3  Mean Δ-albumin increments in Group 1 and Group 2 in con-
secutive days
Fig. 4  Albumin ratios in Group 1 and Group 2 in consecutive days
Fig. 5  Receiver operating characteristic (ROC) curve to determine 
the optimal cut-off of albumin measurements
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factors that might contribute to the diminished albumin drop 
in our patients. Firstly, all our patients underwent laparo-
scopic colorectal surgery. It is known that laparoscopy has 
a positive impact on postoperative stress response, and so 
may contribute to a decreased albumin drop [24]. In addi-
tion, in all our patients ERAS protocol has been used, with a 
high level of adherence. ERAS has been shown to decrease 
stress response in the postoperative period [14]. Moreover, 
one of the key elements of ERAS is balanced/restrictive 
fluid therapy [25–27]. In our opinion, this might have also 
prevented excessive hemodilution in the early hours after 
surgery. All these factors may have an impact on postopera-
tive albumin levels.
The fundamental question is whether the use of albu-
mins in the early postoperative period is clinically relevant. 
It seems that there is no clear answer to this problem. On 
the one hand, the kinetics of albumins makes them perfectly 
suitable as early markers. On the other hand, it drops in any 
increased stress reaction, making albumins less specific. In 
addition, their relationship with the extent of surgery, blood 
loss and fluid resuscitation in the postoperative period can 
introduce many confounding variables which may bias the 
interpretation of results. However, we observed that it is 
not the first drop in the albumin level that differs between 
complicated and uncomplicated patients but rather the trend 
over the next days. If the level continues to decrease, it may 
seem that it is due to an underlying complication, which 
may require further diagnostics or prolonged observation 
in hospital.
The ROC curve analysis showed that measurements on 
POD3 are characterised by the best sensitivity and speci-
ficity. Because albumin measurements are rather unspecific 
in determining the development of complications, we tried 
to increase the specificity using their derivatives. When 
Δ-albumin increments were analysed, thus including the 
Fig. 6  Receiver operating characteristic (ROC) curve to determine 
the optimal cut-off of Δ-albumin measurements
Fig. 7  Receiver operating characteristic (ROC) curve to determine 
the optimal cut-off of albumin ratio measurements (POD0)
Fig. 8  Receiver operating characteristic (ROC) curve to determine 
the optimal cut-off of albumin ratio measurements (POD1)
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baseline levels of albumins in measurements, we observed 
that the sensitivity and specificity on POD 3 were at the 
highest level. Similar observations were made when ratios 
were calculated. Unfortunately, none of these derivatives 
provided better parameters. In our opinion, it is best to meas-
ure albumin levels on consecutive PODs in order to monitor 
their level when searching for postoperative complications. 
Other calculations, with the use of albumin levels, do not 
improve the results.
Our study has certain limitations which are typical for 
a single centre study. We did not assess food charts and 
dietetic preferences of patients. They may have introduced 
confounding factor to the analysis. The study sample is rela-
tively low, especially in the group including patients with 
complications. Besides, we focused only on infectious com-
plications, since albumin, being the negative acute phase 
protein, is strongly correlated with inflammatory response. 
We did not analyse complications with less impact on 
inflammatory status.
Therefore, our observations should be repeated in larger 
cohorts of patients. On the other hand, all patients were 
selected cases, undergoing a similar type of the minimally 
invasive colorectal procedure. The baseline characteristics 
of groups of patients with and without complications, as 
well as the adherence to the protocol were comparable, 
allowing us to draw the conclusion that the differences are 
closely related to occurring complications. In addition, types 
of complications are quite heterogeneous (e.g. surgical site 
infection vs. anastomotic leakage). The whole idea of the 
study was based on the influence of inflammatory reaction 
on changes in albumin levels. Therefore, when planning the 
study, we decided to focus only on inflammatory complica-
tions because albumin, being the negative acute phase pro-
tein, is strongly correlated with inflammatory response. We 
agree that exclusion of other complications (e.g. prolonged 
ileus) might have influenced the final results. For this reason, 
it has to be further investigated whether benefits of albumin 
measurements in the determination of postoperative compli-
cations can be found in all patients, regardless of the sever-
ity, type and underlying cause of complication.
Conclusion
Our study showed that a regular measurement of albumin 
levels in the early postoperative days may be beneficial in 
the detection of postoperative infectious complications. 
Although changes in albumins are observed early after 
surgery, this parameter is relatively unspecific. However, 
consecutive measurements of albumin levels may very well 
serve as an auxiliary biomarker in the monitoring of patients 
after laparoscopic colorectal resections.
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